SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-363633
Filing Date
2021-12-21
Accepted
2021-12-21 16:31:05
Documents
13
Period of Report
2021-12-17
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d26967d8k.htm   iXBRL 8-K 27001
2 EX-3.1 d26967dex31.htm EX-3.1 5304
  Complete submission text file 0001193125-21-363633.txt   156853

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bntc-20211217.xsd EX-101.SCH 2926
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20211217_lab.xml EX-101.LAB 18126
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20211217_pre.xml EX-101.PRE 11428
7 EXTRACTED XBRL INSTANCE DOCUMENT d26967d8k_htm.xml XML 3435
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 211509820
SIC: 2834 Pharmaceutical Preparations